Metabolic Fate of Sipoglitazar a Novel Oral PPAR Agonist with Activities for PPAR-γ, -α and -δ, in Rats and Monkeys and Comparison with Humans In Vitro

Desvergne, 1999, Peroxisome proliferator-activated receptors: nuclear control of metabolism, Endocr. Rev., 20, 649 Balfour, 1990, Fenofibrate.: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia, Drugs, 40, 260, 10.2165/00003495-199040020-00007 Despres, 2001, Increasing high-density lipoprotein cholesterol: an update on fenofibrate, Am. J. Cardiol., 88, 30N, 10.1016/S0002-9149(01)02150-6 Packard, 2002, Comparison of gemfibrozil and fenofibrate in patients with dyslipidemic coronary heart disease, Pharmacotherapy, 22, 1527, 10.1592/phco.22.17.1527.34128 Haffner, 1999, Insulin sensitivity in subjects with T2DM. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study, Diabetes Care, 22, 562, 10.2337/diacare.22.4.562 Balfour, 1999, Rosiglitazone. Drugs, 57, 921, 10.2165/00003495-199957060-00007 Gillies, 2000, Pioglitazone. Drugs, 60, 333, 10.2165/00003495-200060020-00009 Sprecher, 2007, Lipids, lipoproteins, and peroxisome proliferator activated receptor-delta, Am. J. Cardiol., 100, 20N, 10.1016/j.amjcard.2007.08.009 Kim, 1988, Preclinical toxicology and pharmacology of dimethyl- cetamide with clinical notes, Drug Metab. Rev., 19, 345, 10.3109/03602538808994140 Li, 1999, Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential, Chem. Biol. Interact., 121, 17, 10.1016/S0009-2797(99)00088-5 Loretz, 1989, Optimization of cryopreservation procedures for rat and human hepatocytes, Xenobiotica, 19, 489, 10.3109/00498258909042288 Kintscher, 2005, PPARγ-mediated insulin sensitization: the importance of fat versus muscle, Am. J. Physiol. Endocrinol. Metab., 288, E287, 10.1152/ajpendo.00440.2004 Hyneck, 1988, Effect of pH on acyl migration and hydrolysis of tolmetin glucuronide, Drug Metab. Dispos., 16, 322 Smith, 1985, Stability of acyl glucuronides in blood, plasma, and urine: Studies with zomepirac, Drug Metab. Dispos., 13, 110